Verisante Announces Signing of Definitive Agreement for RTO with Myanmar based SIM Co. Ltd.
Vancouver, British Columbia--(Newsfile Corp. - July 9, 2018) - Verisante Technology, Inc. (TSXV: VRS) (the "Company" or "Verisante"), is pleased to announce it has entered into a Definitive Agreement with Myanmar based SIM Co. Ltd. ("SIM") dated June 30, 2018, whereby VRS shall acquire all the issued and outstanding common shares of SIM, a land development Company pursuing construction and operation of an Offshore Supply Base (OSB) to service the awakening oil and gas industry in the...
2018-07-09 10:00 AM EDT
Verisante Announces LOI for RTO with Myanmar based SIM Co. Ltd.
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2018) - Verisante Technology, Inc. (TSXV: VRS) (OTCQX: VRSEF) (the "Company" or "Verisante"), is pleased to announce it has entered into a Letter of Intent with Myanmar based SIM Co. Ltd. ("SIM") dated April 17, 2018, whereby the parties intend to negotiate a Definitive Agreement to complete a business combination by way of a transaction that will constitute a reverse takeover of the Company by SIM (the "RTO"). The resulting issuer that...
2018-04-23 4:41 PM EDT
Verisante Technology, Inc.: Unaware of Any Material Change
Vancouver, British Columbia--(Newsfile Corp. - January 19, 2018) - At the request of IIROC, Verisante Technology, Inc. (TSXV: VRS) ("Verisante" or the "Company") wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity. About Verisante Technology, Inc. Verisante is a medical device company committed to commercializing innovative systems for the early detection of cancer. The...
2018-01-19 12:53 PM EST
Verisante Provides Operational Update
Vancouver, British Columbia--(Newsfile Corp. - May 20, 2016) - Verisante Technology, Inc. (TSXV: VRS) (OTC Pink: VRSEF) (the "Company" or "Verisante"), a leader in skin cancer detection technology, provides an operational update after releasing its financial statements for the year ended December 31, 2015. The Company has begun a program in British Columbia of placing Aura™, a device for the detection of skin cancer, with local partner clinics. Currently, members of the public can visit the...
2016-05-20 4:25 PM EDT